Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celestica (CLS) Current Assets (2016 - 2026)

Celestica has reported Current Assets over the past 18 years, most recently at $6.4 billion for Q1 2026.

  • Quarterly Current Assets rose 46.16% to $6.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.4 billion through Mar 2026, up 46.16% year-over-year, with the annual reading at $5.7 billion for FY2025, 25.73% up from the prior year.
  • Current Assets was $6.4 billion for Q1 2026 at Celestica, up from $5.7 billion in the prior quarter.
  • Over five years, Current Assets peaked at $6.4 billion in Q1 2026 and troughed at $3.6 billion in Q1 2022.
  • The 5-year median for Current Assets is $4.4 billion (2023), against an average of $4.5 billion.
  • Year-over-year, Current Assets grew 0.04% in 2024 and then soared 46.16% in 2026.
  • A 5-year view of Current Assets shows it stood at $4.3 billion in 2022, then increased by 4.24% to $4.5 billion in 2023, then grew by 0.04% to $4.5 billion in 2024, then grew by 25.73% to $5.7 billion in 2025, then increased by 12.76% to $6.4 billion in 2026.
  • Per Business Quant, the three most recent readings for CLS's Current Assets are $6.4 billion (Q1 2026), $5.7 billion (Q4 2025), and $5.1 billion (Q3 2025).